What the name refers to
A topical androgen-receptor antagonist developed for androgenetic alopecia and acne, with regulatory status that varies by jurisdiction.
Evidence and regulatory context
Human clinical research exists, but this entry is not a broadly authorised consumer medicine. Trial results apply to the studied formulation, population and endpoints—not automatically to products sold online.
Reading product records
Route, vehicle and concentration can materially change a topical product. A page about an approved oral or ophthalmic medicine does not automatically validate a compounded hair formulation or an unapproved research product using the same active ingredient.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.